Abbott’s speedy Covid-19 test comes under fire
Abbott’s coronavirus RNA test can ID NOW – but maybe not definitively.
Quidel wins the Covid-19 antigen test race
Antigen tests are faster and cheaper than viral RNA assays, but are notably less accurate.
Roche takes on Abbott in Covid-19 antibody testing
Robust specificity data mark Roche’s serological test out as a major competitor.
The crucial trials Medtronic has had to pause
Covid-19 could mean Medtronic loses out to Abbott, its rival in the mitral valve space.
AACR 2020 – Thrive steals a march
Thrive is in some ways ahead of the competition with the first-ever screening trial of a liquid biopsy, but the test’s sensitivity leaves something to be desired.
Covid-19 antibody tests face a very specific problem
With the prevalence of coronavirus infection running at about 5%, test manufacturers and regulators alike will have to guard against false positives.
New Covid-19 test and a decent first quarter buoy Abbott
Diagnostics prove defensive for Abbott, as the company jumps the FDA’s gun with its third coronavirus test.
FDA authorises the first Covid-19 antibody test
Cellex wins the race to get the FDA’s buy-in for a blood test to pinpoint immunity.
Joint makers report pandemic pain
Sales of implants are set to fall sharply as non-urgent procedures are deferred.
